Adaptive Biotechnologies CEO on the company's IPO and pipeline

Chad Robins, CEO and co-founder of Adaptive Biotechnologies, joins "Squawk Box" ahead of his company's IPO on the Nasdaq. The life sciences and clinical diagnostic company could become the biggest biotech listing of 2019.
Thu, Jun 27 20198:48 AM EDT